The Long Run with Luke Timmerman

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

The Long Run with Luke Timmerman’s tracks

• Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines by The Long Run with Luke Timmerman
• Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer by The Long Run with Luke Timmerman
• Ep167: Leslie Williams on transfer RNA therapies by The Long Run with Luke Timmerman
• Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity by The Long Run with Luke Timmerman
• Ep165: Zach Hornby on Tackling Cancer Drug Resistance by The Long Run with Luke Timmerman
• Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients by The Long Run with Luke Timmerman
• Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases by The Long Run with Luke Timmerman
• Ep162: Sean McClain on AI for Biologic Drug Discovery by The Long Run with Luke Timmerman
• Ep161: Jeff Stein on a Long-Lasting Flu Drug by The Long Run with Luke Timmerman
• Ep160: Abe Ceesay on Precision Neuroscience by The Long Run with Luke Timmerman